Jason Wittes
Stock Analyst at Roth MKM
(2.43)
# 1,052
Out of 4,827 analysts
62
Total ratings
46.3%
Success rate
-0.33%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Buy | $405 → $456 | $382.46 | +19.23% | 11 | May 2, 2025 | |
| ALUR Allurion Technologies | Reiterates: Buy | $16 | $2.36 | +577.97% | 2 | Mar 21, 2025 | |
| MGRM Monogram Technologies | Maintains: Buy | $4 → $5.4 | $2.67 | +102.25% | 2 | Mar 18, 2025 | |
| FBIO Fortress Biotech | Reiterates: Buy | $15 → $16 | $1.69 | +846.75% | 3 | Mar 11, 2025 | |
| OFIX Orthofix Medical | Reiterates: Buy | $22 | $12.31 | +78.72% | 5 | Feb 26, 2025 | |
| IRMD IRADIMED CORPORATION | Reiterates: Buy | $60 → $72 | $52.67 | +36.70% | 3 | Feb 14, 2025 | |
| TLSI TriSalus Life Sciences | Reiterates: Buy | $11 | $5.19 | +111.95% | 2 | Jan 24, 2025 | |
| GMED Globus Medical | Maintains: Buy | $100 → $115 | $72.46 | +58.71% | 4 | Dec 17, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $36 | $6.46 | +457.28% | 1 | Jul 24, 2024 | |
| DERM Journey Medical | Reinstates: Buy | $11 | $6.88 | +59.88% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.14 | +777.12% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $100 | $81.50 | +22.70% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.16 | +131.48% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $1.49 | +504.03% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $33.08 | +126.72% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $12.74 | +72.68% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $95.11 | +26.17% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $153.58 | +34.13% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $199.00 | -27.14% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $8.87 | +69.11% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $17.44 | +1,046.79% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $33.86 | -23.21% | 1 | Feb 22, 2017 |
Stryker
May 2, 2025
Maintains: Buy
Price Target: $405 → $456
Current: $382.46
Upside: +19.23%
Allurion Technologies
Mar 21, 2025
Reiterates: Buy
Price Target: $16
Current: $2.36
Upside: +577.97%
Monogram Technologies
Mar 18, 2025
Maintains: Buy
Price Target: $4 → $5.4
Current: $2.67
Upside: +102.25%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15 → $16
Current: $1.69
Upside: +846.75%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $12.31
Upside: +78.72%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60 → $72
Current: $52.67
Upside: +36.70%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $5.19
Upside: +111.95%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $72.46
Upside: +58.71%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $6.46
Upside: +457.28%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $6.88
Upside: +59.88%
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.14
Upside: +777.12%
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $81.50
Upside: +22.70%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $2.16
Upside: +131.48%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $1.49
Upside: +504.03%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $33.08
Upside: +126.72%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $12.74
Upside: +72.68%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $95.11
Upside: +26.17%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $153.58
Upside: +34.13%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $199.00
Upside: -27.14%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $8.87
Upside: +69.11%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $17.44
Upside: +1,046.79%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $33.86
Upside: -23.21%